Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15325842rdf:typepubmed:Citationlld:pubmed
pubmed-article:15325842lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:15325842lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:15325842lifeskim:mentionsumls-concept:C0920959lld:lifeskim
pubmed-article:15325842lifeskim:mentionsumls-concept:C0042397lld:lifeskim
pubmed-article:15325842lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15325842lifeskim:mentionsumls-concept:C1704711lld:lifeskim
pubmed-article:15325842lifeskim:mentionsumls-concept:C0068964lld:lifeskim
pubmed-article:15325842pubmed:issue18lld:pubmed
pubmed-article:15325842pubmed:dateCreated2004-8-24lld:pubmed
pubmed-article:15325842pubmed:abstractTextNorbormide is a vasoconstrictor of rat peripheral arteries and a relaxant in rat aorta. To characterise norbormide actions within the rat vascular tree we have investigated its effects on the contractile function of rings from several arteries and veins. A maximal norbormide concentration (50 microM) failed to contract thoracic aorta and carotid artery, whereas in pulmonary artery, abdominal aorta, iliac, caudal, and femoral arteries it induced a contractile effect that was respectively 4.8 +/- 0.6, 18.4 +/- 1.5, 39 +/- 5, 144 +/- 7, and 260 +/- 22% of that induced by 90 mM KCl. In pulmonary, carotid, and iliac arteries, and in thoracic and abdominal aorta, 50 microM norbormide inhibited KCl-induced responses. Norbormide (50 microM) contracted all veins investigated. The effect, expressed as % of KCl-induced contraction, was 121 +/- 25, 154 +/- 14.5, 154 +/- 18.2, 203 +/- 19, and 267 +/- 33 for pulmonary vein, thoracic and abdominal vena cava, iliac and jugular veins, respectively. In jugular vein, as previously shown in rat caudal artery, norbormide contraction was abolished in Ca2+-free medium, was unaffected by the Ca2+ channel blocker nifedipine, and was relaxed by SK&F 96365, a blocker of store-operated Ca2+ channels. In conclusion: i) rat veins represent the main target for contractile norbormide action; ii) in both artery and veins norbormide contractions are generally inversely related to the calibre of the vessel; iii) norbormide-induced contraction is mediated by the same mechanism/s in arteries and veins; iiii) in norbormide-contracted arteries the drug activates both contractile and relaxing mechanisms.lld:pubmed
pubmed-article:15325842pubmed:languageenglld:pubmed
pubmed-article:15325842pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15325842pubmed:citationSubsetIMlld:pubmed
pubmed-article:15325842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15325842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15325842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15325842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15325842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15325842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15325842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15325842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15325842pubmed:statusMEDLINElld:pubmed
pubmed-article:15325842pubmed:monthSeplld:pubmed
pubmed-article:15325842pubmed:issn0024-3205lld:pubmed
pubmed-article:15325842pubmed:authorpubmed-author:HopkinsBrianBlld:pubmed
pubmed-article:15325842pubmed:authorpubmed-author:BovaSergioSlld:pubmed
pubmed-article:15325842pubmed:authorpubmed-author:CargnelliGabr...lld:pubmed
pubmed-article:15325842pubmed:authorpubmed-author:CavalliMauriz...lld:pubmed
pubmed-article:15325842pubmed:authorpubmed-author:CimaLorenzoLlld:pubmed
pubmed-article:15325842pubmed:authorpubmed-author:OmiciuoloLuis...lld:pubmed
pubmed-article:15325842pubmed:copyrightInfoCopyright 2004 Elsevier Inc.lld:pubmed
pubmed-article:15325842pubmed:issnTypePrintlld:pubmed
pubmed-article:15325842pubmed:day17lld:pubmed
pubmed-article:15325842pubmed:volume75lld:pubmed
pubmed-article:15325842pubmed:ownerNLMlld:pubmed
pubmed-article:15325842pubmed:authorsCompleteYlld:pubmed
pubmed-article:15325842pubmed:pagination2157-65lld:pubmed
pubmed-article:15325842pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:meshHeadingpubmed-meshheading:15325842...lld:pubmed
pubmed-article:15325842pubmed:year2004lld:pubmed
pubmed-article:15325842pubmed:articleTitleDistribution of the vasoconstrictor and vasorelaxant effects of norbormide along the vascular tree of the rat.lld:pubmed
pubmed-article:15325842pubmed:affiliationDipartimento di Farmacologia ed Anestesiologia, Università degli Studi di Padova, Largo E. Meneghetti 2, 35131 Padova, Italy.lld:pubmed
pubmed-article:15325842pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15325842pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed